AeroLeads people directory · profile

Christopher Conn Email & Phone Number

Director, Precision Medicine - Global Diagnostics Strategy at Amgen
Location: Thousand Oaks, California, United States 13 work roles 2 schools
1 work email found @amgen.com 3 phones found area 303 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email c****@amgen.com
Direct phone (303) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Director, Precision Medicine - Global Diagnostics Strategy
Location
Thousand Oaks, California, United States
Company size

Who is Christopher Conn? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Christopher Conn is listed as Director, Precision Medicine - Global Diagnostics Strategy at Amgen, a company with 35769 employees, based in Thousand Oaks, California, United States. AeroLeads shows a work email signal at amgen.com, phone signal with area code 303, and a matched LinkedIn profile for Christopher Conn.

Christopher Conn previously worked as Director, Clinical Biomarkers & Diagnostics - Global Diagnostics Strategy Lead at Amgen and Scientific Director, Companion Diagnostics Strategy at Abbvie. Christopher Conn holds Ph.D., Cell And Molecular Biology from University Of Cincinnati College Of Medicine.

Company email context

Email format at Amgen

This section adds company-level context without repeating Christopher Conn's masked contact details.

{first_initial}{last}@amgen.com
89% confidence

AeroLeads found 1 current-domain work email signal for Christopher Conn. Compare company email patterns before reaching out.

Profile bio

About Christopher Conn

Precision Medicine Clinical Development Leader with extensive experience across a broad range of functional capacities in precision medicine and companion diagnostics (CDx) from early phase drug development to global registrational CDx co-development programs. Experience building and leading teams. Documented success in developing strategies for and implementing diagnostic testing for clinical development programs across oncology and non-oncology therapeutic areas. Extensive experience in developing and negotiating regulatory strategies with health authorities. Proven success in strategic initiatives including building business cases for new product development and sitting on multiple diligence teams for merger & acquisition analysis. Experience in medical affairs and strategic collaborations. Deep knowledge of multiple diagnostic technologies including PCR, NGS, IHC, digital pathology, flow cytometry and immunoassays.

Listed skills include Companion Diagnostics, Oncology, Clinical Development, Clinical Trials, and 27 others.

Current workplace

Christopher Conn's current company

Company context helps verify the profile and gives searchers a useful next step.

Amgen
Amgen
Director, Precision Medicine - Global Diagnostics Strategy
Thousand Oaks, CA, US
Website
Employees
35769
AeroLeads page
13 roles

Christopher Conn work experience

A career timeline built from the work history available for this profile.

Director, Precision Medicine - Global Diagnostics Strategy

Thousand Oaks, CA, US

Director, Clinical Biomarkers & Diagnostics - Global Diagnostics Strategy Lead

Current

Thousand Oaks, CA, US

Sep 2022 - Present

Scientific Director, Companion Diagnostics Strategy

North Chicago, Illinois, US

  • Responsible for the overarching global CDx strategy across projects in targeted therapeutic areas
  • Lead the development and implementation of diagnostic strategies for individual projects and/or therapeutic areas
  • Direct the development, outsourcing and validation of clinically applicable companion diagnostic assays for FIH and registrational studies
  • Design, implement and oversee diagnostic testing and data analysis
  • Provide expertise to development project teams to ensure access to state-of-the-art thinking on appropriate diagnostic technologies, evaluating their scientific basis and clinical applicability, the validation status.
  • Lead joint development teams between AbbVie and Dx partners to ensure co-development timelines are met
Aug 2020 - Sep 2022

Principal Scientist - Global Companion Diagnostics Lead

Thousand Oaks, CA, US

Responsible for developing and implementing the overall companion diagnostic strategy for several therapeutic programs spanning early to late phase clinical development.

Jul 2018 - Aug 2020

Sr. Manager, Companion Diagnostics & Translational Medicine

Array Biopharma Inc. (Acquired By Pfizer In 2019)
  • Led the companion diagnostic and translational biomarker efforts for several assets in various stages of clinical development from phase I to phase III to include:
  • Represent translational medicine and companion diagnostics on study teams, core teams or other cross-functional teams
  • Responsible for companion diagnostic and translational biomarker sections of clinical protocols, CRFs, CSRs, IBs, lab manuals, regulatory submissions, etc.
  • Responsible for partner selection, alliance management, budgeting and overall strategy development for CDx portions of development programs
  • Serve as regulatory lead for all interactions with the FDA regarding CDx development
  • Regularly interface with external vendors and CROs involved in biomarker services and serve as technical lead in negotiations with and auditing of these partners
Apr 2016 - Jul 2018

Manager, New Product Development - Emerging Products

Salt Lake City, Utah, US

Led strategy development & new product planning for pipeline products in oncology portfolio- Clinical Development Planning- Market Analysis, Competitive Intelligence- New Technology Evaluation and due dilligence- Perform primary and secondary market research to inform new product development - New product concept business case development

Apr 2014 - Apr 2016

Global Medical Scientific Affairs - Mdx Market Management Team

Venlo, Limburg, NL

- Global pipeline strategy for oncology companion diagnostics and personalized medicine.- Supported corporate BD through the scientific, medical and technical assessment of biomarker in-licensing and acquisition opportunities.- Market entrance strategy & business intelligence.- KOL Management & Strategic Alliances

Nov 2012 - Apr 2014

Global Market Development Manager

Venlo, Limburg, NL

Grew market presence of quantitative PCR and laboratory developed test (LDT) workflow through partnerships and strategic alliances with key opinion leaders. Led market research to guide product development strategy and identified and developed programs to support expansion into new market areas.

Jul 2011 - Oct 2012

Senior Applications Development Manager

Venlo, Limburg, NL

Sep 2007 - Jun 2011

Research Associate

Chevy Chase, Maryland, US

Postdoctoral studies in the department of Pharmacology/University of Colorado Cancer Center with emphasis on kinase regulation and mechanisms of response to DNA damage in molecular oncology under the direction of Dr. James L. Maller.

Feb 2002 - Aug 2004

Postdoctoral Fellow

Memphis, TN, US

Postdoctoral studies in the department of Genetics and Tumor Cell Biology with emphasis on the mechanisms of tumor suppression and leukemogenesis under the direction of Dr. Charles J. Sherr and Dr. Martine F. Roussel

Jan 2001 - Jan 2002
Team & coworkers

Colleagues at Amgen

Other employees you can reach at amgen.com. View company contacts for 35769 employees →

2 education records

Christopher Conn education

Ph.D., Cell And Molecular Biology

University Of Cincinnati College Of Medicine

B.S., Biology

Lee University
FAQ

Frequently asked questions about Christopher Conn

Quick answers generated from the profile data available on this page.

What company does Christopher Conn work for?

Christopher Conn works for Amgen.

What is Christopher Conn's role at Amgen?

Christopher Conn is listed as Director, Precision Medicine - Global Diagnostics Strategy at Amgen.

What is Christopher Conn's email address?

AeroLeads has found 1 work email signal at @amgen.com for Christopher Conn at Amgen.

What is Christopher Conn's phone number?

AeroLeads has found 3 phone signal(s) with area code 303 for Christopher Conn at Amgen.

Where is Christopher Conn based?

Christopher Conn is based in Thousand Oaks, California, United States while working with Amgen.

What companies has Christopher Conn worked for?

Christopher Conn has worked for Amgen, Abbvie, Array Biopharma Inc. (Acquired By Pfizer In 2019), Myriad Genetics, and Qiagen.

Who are Christopher Conn's colleagues at Amgen?

Christopher Conn's colleagues at Amgen include Mhairi Strachan, Farzana Bhuiyan, Amy Michel, Hahna Kaiser, and Elena Kryzhanovskaya.

How can I contact Christopher Conn?

You can use AeroLeads to view verified contact signals for Christopher Conn at Amgen, including work email, phone, and LinkedIn data when available.

What schools did Christopher Conn attend?

Christopher Conn holds Ph.D., Cell And Molecular Biology from University Of Cincinnati College Of Medicine.

What skills is Christopher Conn known for?

Christopher Conn is listed with skills including Companion Diagnostics, Oncology, Clinical Development, Clinical Trials, Molecular Diagnostics, Strategic Alliances, Regulatory Affairs, and Product Development.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.